Abraham N. Ceesay owns 1.15% of Rapport Therapeutics
552,493 shares as of the October 21, 2026 filing, worth $14M at the latest close.
RAPP · $1.2B market capGet an email when Abraham N. Ceesay’s stake moves.
Free.
The stake
1.15%
worth $14M at the latest close
Stake rank
#1,487
by dollar value of the stake
Last sale
6 days ago
Oct 21, 2026
Last buy
None
no purchases since 2025
Abraham N. Ceesay owns 1.15% of Rapport Therapeutics, Inc.: 552,493 of 47,978,286 shares, worth about $14M at the 2026-10-26 close. The stake has moved from 2.16% in 2024 to 1.15% on 2026-10-21, across 15 sales and 0 purchases that moved it since 2016. The last trade that moved it was a planned sale of $64,448 on 2026-10-21.
How the stake is held
as of the Oct 21, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Oct 21, 2026 · Form 4 ↗
HELD DIRECTLY
450,035
81.5%
HELD INDIRECTLY · 2 VEHICLES
102,458
18.5%
By Ceesay Family Irrevocable Trust
81,729
14.8%
By Dorothy Ceesay Irrevocable Trust
20,729
3.8%
THE STAKE
552,493
1.15%